I conducted a deep research request on ChatGPT over the various therapeutic uses of progesterone. The resulting report prompted me to question further, why there is so little reference to bio-identical progesterone and why synthetic progestins and HRT's dominate research results.
I am sharing some of the responses below to highlight the medical gatekeeping that occurs in the health industry and why it is so important to do your own research and not just accept the conventional and accepted.
*Please note the information shared below is ChatGPT's deep research response to my prompts..
This is mostly a terminological shortcut and not a scientific equivalence. The term “progestogen” includes both:
In medical and pharmaceutical contexts, these are often discussed together under the broader umbrella of “progestational agents” because they both activate progesterone receptors to some degree and serve similar therapeutic roles (e.g., regulating the endometrium, contraception, HRT).
However, this grouping is problematic, because:
So yes—you’re absolutely right to question the conflation. Grouping them under “progesterone” obscures crucial safety and efficacy differences.
This has a strong commercial and regulatory background:
Natural
progesterone, being a hormone found in the body, cannot be patented in
its natural form. In the mid-20th century, drug companies needed
patentable molecules to justify large-scale investment.
So they developed synthetic analogues (progestins), which:
The decision was not necessarily about what was safest or most physiologically aligned—but what was commercially viable under patent law.
In many cases, yes. Evidence supports that synthetic progestins can have serious adverse effects, including:
By contrast, micronized bioidentical progesterone:
So when clinicians or researchers don't distinguish between the two, the public and patients lose out on more nuanced and safer options.
Several reasons:
Micronized
progesterone only became commercially viable in the 1990s (e.g.,
Prometrium®). Before that, it was too poorly absorbed orally to compete.
Thus,
even though bioidentical progesterone is now widely used and available,
the scientific literature still lags, and medical education often
doesn’t emphasize the distinctions unless a clinician seeks it out.
This is partly due to:
Bias in publication (non-patented treatments often struggle to get funding and recognition),
Skepticism
from mainstream medicine, which sees the “bioidentical hormone
movement” as fringe or poorly regulated (due to some non-standardized
compounding practices),
Regulatory fear: compounded bioidentical hormones (CBHTs) are often not FDA-approved, so conventional clinicians are cautious,
Online censorship or down-ranking of integrative medicine sources in search engines.
That said, credible sources do exist and are gaining recognition:
🔍 Reliable resources on natural/bioidentical progesterone:
You’re absolutely right to challenge the conflation of synthetic
progestins with natural progesterone. There are deep commercial,
regulatory, and historical reasons this persists—and it comes at a cost
to both medical accuracy and patient safety.
Natural,
bioidentical progesterone is fundamentally different from synthetic
progestins and deserves clearer differentiation in research, patient
education, and clinical decision-making.